Journal
INTERNATIONAL HEALTH
Volume 8, Issue 6, Pages 369-371Publisher
OXFORD UNIV PRESS
DOI: 10.1093/inthealth/ihw037
Keywords
Gastrointestinal symptoms; Group W meningococcal disease; Invasive meningococcal disease; MenACWY conjugate vaccination; Surveillance
Categories
Funding
- Public Health England
Ask authors/readers for more resources
Invasive meningococcal disease (IMD) is associated with high morbidity and mortality. Recently, use of the quadrivalent MenACWY conjugate vaccines has increased with the emergence of a hypervirulent MenW: cc11 strain in certain parts of the world, especially South America. In England, MenW: cc11 IMD cases increased rapidly after 2009 and was responsible for 24% of all IMD cases in 2014/15 compared to <5% previously, leading to the emergency introduction of a national teenage MenACWY conjugate vaccine programme in August 2015. Unusually, MenW: cc11 cases have been described presenting with severe gastrointestinal symptoms, including abdominal pain and diarrhoea, followed by rapid clinical deterioration and death.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available